Literature DB >> 22138941

Editorial: bugs and drugs: insights into the pathogenesis of inflammatory bowel disease.

Geoffrey C Nguyen.   

Abstract

The dysbiosis hypothesis posits that perturbations in the gut microbiome may contribute to the development of inflammatory bowel disease (IBD). A recent Canadian population-based study has shown an association between new-onset IBD and antibiotic use in the 2-5 years preceding diagnosis. Though these findings do not establish a causal relationship, it supports the role of dysbiosis in the pathogenesis of IBD. Furthermore, the study reinforces the importance of the judicious use of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138941     DOI: 10.1038/ajg.2011.308

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  The canine gastrointestinal microbiota: early studies and research frontiers.

Authors:  Zongyu Huang; Zhiyuan Pan; Ruifu Yang; Yujing Bi; Xiaohui Xiong
Journal:  Gut Microbes       Date:  2020-01-28

2.  Onset of Ulcerative Colitis after Helicobacter pylori Eradication Therapy: A Case Report.

Authors:  Mitsuro Chiba; Tsuyotoshi Tsuji; Kenichi Takahashi; Masafumi Komatsu; Takeshi Sugawara; Iwao Ono
Journal:  Perm J       Date:  2016-03-21

Review 3.  Current Understanding of Dysbiosis in Disease in Human and Animal Models.

Authors:  Arianna K DeGruttola; Daren Low; Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

Review 4.  Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.

Authors:  Israr Khan; Naeem Ullah; Lajia Zha; Yanrui Bai; Ashiq Khan; Tang Zhao; Tuanjie Che; Chunjiang Zhang
Journal:  Pathogens       Date:  2019-08-13

Review 5.  The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.

Authors:  Md Mominur Rahman; Fahadul Islam; Md Harun -Or-Rashid; Abdullah Al Mamun; Md Saidur Rahaman; Md Mohaimenul Islam; Atkia Farzana Khan Meem; Popy Rani Sutradhar; Saikat Mitra; Anjuman Ara Mimi; Talha Bin Emran; Rinaldi Idroes; Trina Ekawati Tallei; Muniruddin Ahmed; Simona Cavalu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-20       Impact factor: 6.073

Review 6.  Pathogenetic Impact of Bacterial-Fungal Interactions.

Authors:  Filomena Nogueira; Shirin Sharghi; Karl Kuchler; Thomas Lion
Journal:  Microorganisms       Date:  2019-10-16

Review 7.  Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease.

Authors:  Edda Russo; Francesco Giudici; Camilla Fiorindi; Ferdinando Ficari; Stefano Scaringi; Amedeo Amedei
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.